BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancer

PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Oct. 04, 2023 -- BriaCell Therapeutics Corp. , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer...

Related Keywords

Staten Island ,New York ,United States ,Canada ,Nassau ,New Providence ,Bahamas ,The ,Philadelphia ,Pennsylvania ,Vancouver ,British Columbia ,United Kingdom ,Brooklyn ,Long Island ,Toronto ,Ontario ,Canadian ,British ,Jules Abraham ,Williamv Williams ,Jeffrey Vacirca ,Company Contact ,Toronto Stock Exchange ,Nasdaq ,Regulation Services Provider ,Briacell Therapeutics Corp ,Exchange Commission ,Globenewswire Inc ,Cell Therapeutics ,New York Cancer ,York City ,Upstate New York ,Del Priore ,Chief Medical ,York Metropolitan ,Annual Information Form ,Stock Exchange ,Relations Contact ,Markets ,